EFSA denies ties to biotech industry

The European Food Safety Authority has defended its independence from the biotech industry following renewed accusations from environmentalists that the EU agency ignores evidence of the potential health risks of genetically modified products. Tipping off the accusations was a study by the University of Caen, published last month, which found that rats fed on a diet containing NK603 - a maize seed variety doused with Monsanto's Roundup herbicide - or given water with Roundup at levels permitted in the United States, died earlier than those on a standard diet. The EU food agency’s initial review said the analysis contained in the study, led by biologist Gilles-Éric Séralini, was insufficient and asked for additional evidence. EFSA Executive Director Catherine Geslain-Lanéelle told journalists in Brussels on Friday (12 October) that EFSA's review had been conducted by seven to eight people and was also backed by the Dutch and German risk assessment authorities. "This is about the quality of scientific data. The data you are using should respect good scientific standard. The debate has sometimes been a bit too emotional," she said. EFSA's executive director added that she believes the debate has been specifically fierce this time, due to the photos published by the Caen researchers showing rats with tumours and abnormal organs.

Asked by EurActiv whether EFSA listens too carefully to the biotech industry, Geslain-Lanéelle said: "I would like to say that there is no evidence of that. We regularly have meetings with NGOs and organisations like Friends of the Earth. We invite them. Some organisations might want that impression to circulate, but it's untrue." She stressed that EFSA has "very strict" rules when it comes to its staff of experts, advisors, management and assistants to make sure they do not have a conflict of interest. For example, people who have worked for the pesticide industry cannot be considered for a job at EFSA. Even though EFSA "has nothing to protect but public health", the food agency does not have an opinion about whether GMO food products belong in Europe. "It's not our role to say whether we like GMOs or not," Geslain-Lanéelle said. "We are just here to access the risk. This does not ease our work because we are scientists and we work in a very political environment," she added. Geslain-Lanéelle also added that EFSA is "open", and new scientific evidence will be taken seriously as it might make the food agency reconsider an assessment of previous scientific studies. From 2007-2011, EFSA has had seven requests of publishing data. Geslain-Lanéelle said EFSA's data have been made public and shared as it is not confidential, but it is not available online. In general, it is the European Commission which decides when data in a report should be confidential. Usually, that applies to sequences of genes for GMOs.

Source: AllAboutFeed, 19 Oct 2012
http://www.allaboutfeed.net/Nutrition/General/2012/10/EU-food-safety-ag…

Henk Tennekes

Sun, 10/21/2012 - 11:37

Seralini's data clearly demand immediately a follow up carcinogenicity study, paid by industry but conducted by independent scientists, to properly evaluate the carcinogenic potential of these products (GM maize and total Roundup formulation). Patrick Holden and Micheal Antoniou talking on GE corn/cancer link: http://gefreebc.wordpress.com/2012/09/27/more-reports-and-resources-on-…

Henk Tennekes

Sun, 10/21/2012 - 18:28

Professor Gilles-Eric Séralini, professor of molecular biology at Caen university in France, knows how to inflame the GM industry and its friends. For seven years he and his team have questioned the safety standards applied to varieties of GM maize and tried to re-analyse industry-funded studies presented to governments.

The GM industry has traditionally reacted furiously and personally. Séralini has been widely insulted and smeared and last year, in some desperation, he sued Marc Fellous, president of the French Association of Plant Biotechnology, for defamation, and won (although he was only awarded a nominal €1 in damages).

But last week, Seralini brought the whole scientific and corporate establishment crashing down on his head. In a peer-reviewed US journal, Food and Chemical Toxicology, he reported the results of a €3.2m study. Fed a diet of Monsanto's Roundup-tolerant GM maize NK603 for two years, or exposed to Roundup over the same period, rats developed higher levels of cancers and died earlier than controls. Séralini suggested that the results could be explained by the endocrine-disrupting effects of Roundup, and overexpression of the transgene in the GMO.

This was scientific dynamite. It was the first time that maize containing these specific genes had been tested on rats over two years - nearly their full lifespan - as opposed to the 90-day trials demanded by regulators. Around a dozen long-term studies of different GM crops have failed to find similar effects. Séralini's study also looked at the toxicity of the Roundup herbicide when fed directly to rats.

If the study stood up, then the consistent arguments of the industry that its GM maize is safe might be fatally undermined, with immense political, financial and social consequences.

But barely had the paper surfaced than it was attracting heavyweight academic criticism.

Commentators variously claimed the study to be "biased", "poorly performed", "bogus", "fraudulent", "sub-standard", "sloppy agenda-based science", "inadequate" and "unsatisfactory". Séralini was said to have "sought harm" for the rats, the experiment was dismissed as "inhumane" and the research group was called "partisan". France was outed as "the most anti-science country in anti-science Europe" and vociferous GM supporters such as Mark Lynas urged people to sign a petition demanding full disclosure of the data (only a few hundred have).

Meanwhile, GM opponents were said to be the "climate skeptics of the left", Séralini and his scientists were labelled "crafty activists" and "anti-science" and the group that funded the study was accused of "polluting science communication" by asking for an embargo on the paper.

Séralini and the other authors of the study responded that they were surprised at the "violence" of their critics.

But it was a triumph for the scientific and corporate establishment which has used similar tactics to crush other scientists like Arpad Pusztai of the Rowett Institute in Scotland, who was sacked after his research suggested GM potatoes damaged the stomach lining and immune system of rats, and David Quist and Ignacio Chapela, who studied the flow of genes from illegally planted GM maize to Mexican wild maize. But now that the dust is settling, let's look at some of the criticisms and Seralini's responses.

"This is not an innocent scientific publication. The study was designed to produce exactly what was observed," said Dr Bruce Chassy, professor emeritus of food science at the University of Illinois, who has worked as a consultant for GM companies and has been a member of the US Food and Drug Administration's Food Advisory Council which is fully behind GM.

"This study appears to be without scientific merit," said Martina Newell-McGloughlin, director of the International Biotechnology Program at the University of California/Davis, which has close links to Monsanto and other GM companies.

"Although this paper has been published in a peer–reviewed journal with an [Impact Factor] of about 3, there are anomalies throughout the paper that normally should have been corrected or resolved through the peer-review process," said Maurice Moloney, InsChief Executive of Rothamsted Research.

"The control group is inadequate to make any deduction," said Anthony Trewavas, prominent champion of GM food and a former member of the governing council of Britain's leading plant biotech research organisation, the John Innes Centre.

"We have to ask whether a diet with this level of maize is normal for rats. Another control with an alternative diet should have been included," said Dr Wendy Harwood, senior scientist at the John Innes Centre.

Monsanto was dismissive: "This study does not meet minimum acceptable standards for this type of scientific research, the findings are not supported by the data presented, and the conclusions are not relevant for the purpose of safety assessment."

Here are the criticisms in a nutshell and Séralini's responses:

1. The French researchers were accused of using the Sprague Dawley rat strain which is said to be prone to developing cancers. In response Séralini and his team say these are the same rats as used by Monsanto in the 90-day trials which it used to get authorisation for its maize. This strain of rat has been used in most animal feeding trials to evaluate the safety of GM foods, and their results have long been used by the biotech industry to secure approval to market GM products.

2. The sample size of rats was said to be too small. Séralini responded that six is the OECD recommended protocol for GM food safety toxicology studies and he had based his study on the toxicity part of OECD protocol no. 453. This states that for a cancer trial you need a minimum of 50 animals of each sex per test group but for a toxicity trial a minimum of 10 per sex suffices. Monsanto used 20 rats of each sex per group in its feeding trials but only analysed 10, the same number as Séralini.

3. No data was given about the rats' food intake. Seralini says the rats were allowed to eat as much food as they liked.

4. Séralini has not released the raw data from the trial. In response he says he won't release it until the data underpinning Monsanto's authorisation of NK603 in Europe is also made public.

5. His funding was provided by an anti-biotechnology organisation whose scientific board Séralini heads. But he counters that almost all GM research is funded by corporates or by pro-biotech institutions.

So where does that leave the public?

Despite the concerns over Séralini's methodological flaws, it looks as though the study will not be swept under the carpet. It is the longest study done on this variety of maize and many argue that it must be taken seriously by regulators and governments. French health and safety authorities now plan to investigate NK603 and the study's findings and the European Food Safety Agency has said it will assess the research. Séralini is now demanding that all the data be assessed by an independent international committee, arguing that experts involved in the authorisation of the maize should not be involved.

Equally, the study reopens questions about the regulation of GM crops. There has long been concern that these foods have been evaluated poorly and that the companies have taken advantage of lax regulation. The GM industry, which keeps its own research secret, has resisted investigation or any change.

In fact, there is one irony that a few scientists have pointed out but who have been drowned out in the furore. Séralini's study was not so much about the dangers of GM technology, but the toxicity of the Roundup herbicide used on the crops. Here's Ottoline Leyser, associate director of the Sainsbury Laboratory, University of Cambridge:

"Like most of the GM debate, this work has very little to do with GM. The authors of the paper do not suggest that the effects are caused by genetic modification. They describe effects of the roundup herbicide itself and effects that they attribute to the activity of the enzyme introduced into the roundup resistant maize. There is good evidence that introducing genes into crops using GM techniques results in fewer changes to the crops than introducing them using conventional breeding."

Source: The Guardian, 28 September 2012
http://www.guardian.co.uk/environment/2012/sep/28/study-gm-maize-cancer